Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Gregorio Tersalvi1, Marco Vicenzi2, Davide Calabretta3
1Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland; Department of Internal Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland.
Insights
Elevated cardiac troponin indicates myocardial injury in patients with Coronavirus disease 2019 (COVID-19). This heart muscle damage is linked to severe illness and higher mortality rates in COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic causing significant mortality.
- Critical COVID-19 presentations often involve overwhelmed healthcare systems.
- Elevated cardiac troponin levels have been observed in a substantial proportion of COVID-19 patients.
Purpose of the Study:
- To explore the association between COVID-19 and myocardial injury.
- To review the evidence linking cardiac troponin levels to COVID-19 severity and outcomes.
Main Methods:
- Literature review of studies analyzing COVID-19 patient data.
- Examination of evidence on myocardial injury markers, specifically cardiac troponin.
- Analysis of the correlation between troponin levels and patient mortality.
Main Results:
- Elevated cardiac troponin is a frequent finding in COVID-19 patients.
- Myocardial injury is implicated as a pathogenic mechanism in severe COVID-19.
- High troponin levels are significantly associated with increased mortality in COVID-19.
Conclusions:
- Myocardial injury, indicated by elevated cardiac troponin, is a critical factor in COVID-19 prognosis.
- Cardiac troponin levels serve as a potential biomarker for predicting mortality in COVID-19 patients.
- Understanding the link between COVID-19 and myocardial injury is crucial for patient management.
Abstract:
Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 1.8 million people worldwide, overwhelmed health care systems owing to the high proportion of critical presentations, and resulted in more than 100,000 deaths. Since the first data analyses in China, elevated cardiac troponin has been noted in a substantial proportion of patients, implicating myocardial injury as a possible pathogenic mechanism contributing to severe illness and mortality. Accordingly, high troponin levels are associated with increased mortality in patients with COVID-19. This brief review explores the available evidence regarding the association between COVID-19 and myocardial injury.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
